Therapeutic effects of gemcitabine on cutaneous manifestations in an Adamantiades-Behçet's disease-like mouse model.
Sohn
Seonghyang
S
Laboratory of Cell Biology, Ajou University Institute for Medical Sciences, Suwon, South Korea.
Lutz
Manfred
M
Kwon
Hyuk Jae
HJ
Konwalinka
Guenther
G
Lee
Sungnack
S
Schirmer
Michael
M
D000410:Alanine Transaminase / Q000032:analysis; D000818:Animals; D001528:Behcet Syndrome / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D016207:Cytokines / Q000097:blood; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D006561:Herpes Simplex / Q000150:complications; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D051379:Mice; D008813:Mice, Inbred ICR; D012883:Skin Ulcer / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D000093542:Gemcitabine
D016207:Cytokines; D007166:Immunosuppressive Agents; D003841:Deoxycytidine; D000410:Alanine Transaminase; D000093542:Gemcitabine